Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Furosemide | Lasix | 4.4 Special Warnings and Special Precautions for Use | Hearing loss in neonates, including premature neonates. | Mar,2023 |
| Cefixime | Suprax | "4.4. Special warnings and precautions for use 4.8 Undesirable effects" | "Antibiotic-associated colitis Urticaria, Rash, Pruritus, Acute generalised exanthematous pustulosis(AGEP) , General disorders and administrative site conditions: Drug Fever, Arthralgia" | Feb,2024 |
| Femara | Letrozole | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Tendon disorders, specifically, tendonitis, tenosynovitis and tendon rupture | Mar,2023 |
| Cephalexin | Keflex | 4.4 Special Warnings and Special Precautions for Use | Seizures | Mar,2023 |
| Telmisartan | Micardis | 4.8. Undesirable Effects | Hyponatremia | Dec,2022 |
| Mercaptopurine | Purinethol | 4.8. Undesirable effects | Erythema nodosum | Dec,2022 |